Biopharmaceuticals

Fuatilia
Illustration of Amazonian scorpion venom research showing potential against breast cancer, with lab equipment and scientists.
Picha iliyoundwa na AI

Amazonian scorpion venom peptide shows paclitaxel-like action against breast cancer cells in lab tests

Imeripotiwa na AI Picha iliyoundwa na AI Imethibitishwa ukweli

Researchers in Brazil have identified a molecule in the venom of the Amazonian scorpion Brotheas amazonicus that kills breast cancer cells in vitro with effects similar to the chemotherapy drug paclitaxel, according to FAPESP. Early tests indicate the peptide chiefly induces necrosis, underscoring venoms’ promise as a source of biopharmaceuticals.

Tovuti hii inatumia vidakuzi

Tunatumia vidakuzi kwa uchambuzi ili kuboresha tovuti yetu. Soma sera ya faragha yetu kwa maelezo zaidi.
Kataa